Legend Biotech (LEGN) Competitors $43.36 -0.85 (-1.92%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$43.23 -0.13 (-0.31%) As of 07/25/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LEGN vs. BNTX, SMMT, INSM, TEVA, GMAB, RDY, MRNA, QGEN, VTRS, and ASNDShould you be buying Legend Biotech stock or one of its competitors? The main competitors of Legend Biotech include BioNTech (BNTX), Summit Therapeutics (SMMT), Insmed (INSM), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Qiagen (QGEN), Viatris (VTRS), and Ascendis Pharma A/S (ASND). These companies are all part of the "pharmaceutical products" industry. Legend Biotech vs. Its Competitors BioNTech Summit Therapeutics Insmed Teva Pharmaceutical Industries Genmab A/S Dr. Reddy's Laboratories Moderna Qiagen Viatris Ascendis Pharma A/S Legend Biotech (NASDAQ:LEGN) and BioNTech (NASDAQ:BNTX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings. Is LEGN or BNTX more profitable? BioNTech has a net margin of -27.37% compared to Legend Biotech's net margin of -29.95%. BioNTech's return on equity of -3.94% beat Legend Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Legend Biotech-29.95% -21.19% -13.47% BioNTech -27.37%-3.94%-3.41% Do analysts rate LEGN or BNTX? Legend Biotech presently has a consensus target price of $73.33, suggesting a potential upside of 69.13%. BioNTech has a consensus target price of $136.58, suggesting a potential upside of 18.45%. Given Legend Biotech's stronger consensus rating and higher probable upside, research analysts plainly believe Legend Biotech is more favorable than BioNTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Legend Biotech 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91BioNTech 0 Sell rating(s) 4 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.83 Do insiders & institutionals hold more shares of LEGN or BNTX? 70.9% of Legend Biotech shares are held by institutional investors. Comparatively, 15.5% of BioNTech shares are held by institutional investors. 0.0% of Legend Biotech shares are held by company insiders. Comparatively, 19.2% of BioNTech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more risk & volatility, LEGN or BNTX? Legend Biotech has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Comparatively, BioNTech has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Does the media prefer LEGN or BNTX? In the previous week, Legend Biotech had 1 more articles in the media than BioNTech. MarketBeat recorded 9 mentions for Legend Biotech and 8 mentions for BioNTech. Legend Biotech's average media sentiment score of 1.34 beat BioNTech's score of 0.51 indicating that Legend Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Legend Biotech 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioNTech 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, LEGN or BNTX? Legend Biotech has higher earnings, but lower revenue than BioNTech. Legend Biotech is trading at a lower price-to-earnings ratio than BioNTech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLegend Biotech$627.24M12.70-$177.03M-$0.59-73.49BioNTech$2.98B9.31-$719.92M-$3.40-33.91 SummaryLegend Biotech and BioNTech tied by winning 8 of the 16 factors compared between the two stocks. Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LEGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LEGN vs. The Competition Export to ExcelMetricLegend BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.97B$3.05B$5.70B$9.50BDividend YieldN/A2.37%4.58%4.00%P/E RatioN/A21.3228.3920.07Price / Sales12.70270.06427.4498.54Price / CashN/A42.7636.2258.56Price / Book7.618.378.675.88Net Income-$177.03M-$55.19M$3.25B$258.89M7 Day Performance4.26%5.86%4.30%3.70%1 Month Performance29.51%17.29%10.57%11.71%1 Year Performance-23.41%4.39%35.68%17.98% Legend Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LEGNLegend Biotech3.6964 of 5 stars$43.36-1.9%$73.33+69.1%-26.7%$7.97B$627.24M0.002,609Positive NewsBNTXBioNTech1.4221 of 5 stars$108.91-1.0%$136.58+25.4%+36.2%$26.18B$2.98B-32.036,772News CoverageSMMTSummit Therapeutics2.5068 of 5 stars$26.34+0.5%$34.67+31.6%+173.3%$19.56B$700K-77.47110Positive NewsINSMInsmed3.9249 of 5 stars$102.78+0.2%$108.47+5.5%+39.5%$19.50B$363.71M-17.271,271News CoverageAnalyst ForecastInsider TradeTEVATeva Pharmaceutical Industries4.0118 of 5 stars$16.30+1.5%$24.71+51.7%-1.6%$18.69B$16.54B-14.1736,830Positive NewsUpcoming EarningsAnalyst UpgradeGap UpGMABGenmab A/S4.0851 of 5 stars$21.69-0.9%$37.80+74.3%-16.8%$13.92B$3.12B12.322,682Positive NewsRDYDr. Reddy's Laboratories2.7387 of 5 stars$14.57+0.6%$16.95+16.4%-9.3%$12.16B$3.81B22.0727,811Earnings ReportMRNAModerna4.2974 of 5 stars$30.97-0.9%$46.61+50.5%-71.6%$11.98B$3.24B-3.555,800Upcoming EarningsAnalyst ForecastQGENQiagen3.6745 of 5 stars$48.06-0.6%$49.40+2.8%+26.1%$10.68B$1.98B120.495,765Analyst DowngradeAnalyst RevisionVTRSViatris2.432 of 5 stars$8.90+0.2%$10.40+16.9%-20.0%$10.45B$14.74B-2.8132,000ASNDAscendis Pharma A/S3.4338 of 5 stars$168.02-1.1%$223.07+32.8%+24.6%$10.39B$368.70M-26.751,017Analyst Revision Related Companies and Tools Related Companies BNTX Alternatives SMMT Alternatives INSM Alternatives TEVA Alternatives GMAB Alternatives RDY Alternatives MRNA Alternatives QGEN Alternatives VTRS Alternatives ASND Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LEGN) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Corporation Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
